Critical Therapeutics, Inc. Announces Pricing of Initial Public Offering.Business Editors/Health/Medical Writers LEXINGTON, Mass.--(BUSINESS WIRE)--May 27, 2004 Critical Therapeutics, Inc. (Nasdaq: CRTX) announced today the pricing of its initial public offering of 6,000,000 shares of its common stock at a price of $7.00 per share. All of the shares are being sold by Critical Therapeutics. In addition, Critical Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares to cover over-allotments, if any. Critical Therapeutics' common stock is expected to begin trading on the Nasdaq National Market on May 27, 2004 under the symbol "CRTX." The managing underwriters for this offering are SG Cowen & Co., LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , acting as sole book-running manager, and CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities. Corp., Piper Jaffray Piper Jaffray & Co. (NYSE: PJC), often shortened to just Piper Jaffray or PiperJaffray, is a U.S. middle-market investment banking firm based in Minneapolis, Minnesota and is a focused on delivering financial advice, investment products and transaction execution & Co. and Leerink Swann & Company, acting as co-managers. Copies of the final prospectus Final Prospectus A legal document stating the price of a newly issued security, the delivery date, and other facts that are important for investors. Notes: The final prospectus must be given to every investor who purchases a new issue of registered securities. relating to this offering may be obtained from SG Cowen & Co., LLC, 1221 Avenue of the Americas, New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY 10020 or through ADP (1) (Automatic Data Processing) Synonymous with data processing (DP), electronic data processing (EDP) and information processing. (2) (Automatic Data Processing, Inc., Roseland, NJ, www.adp. by fax at (631) 254-7268. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Critical Therapeutics Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of products designed to regulate the inflammatory response associated with asthma and critical care diseases. The company is developing a sales and marketing infrastructure in connection with its in-licensed asthma product, zileuton zileuton /zi·leu·ton/ (zi-loo´ton) an inhibitor of leukotriene formation, used as an antiasthmatic. Zileuton (Zyflo) . Critical Therapeutics is also developing treatments directed toward the severe inflammatory response in acute diseases and conditions that lead to admission to the emergency room or intensive care unit, and acute exacerbations of other chronic diseases that frequently lead to hospitalization. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion